On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

RAG1

recombination activating 1

The RAG1 gene provides instructions for a protein crucial in the development and diversity of immune cells, playing a key role in the body's ability to recognise and fight infections. The RAG1 gene encodes a protein that is a vital component of the RAG complex, which is active in B and T lymphocytes.

Chromosome 11p12 Autosomal recessive HGNC:9831 Tier C
RAG1 11p12 p arm q arm 11

RAG1 is located on the short (p) arm of chromosome 11, at band 11p12. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 11 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The RAG1 gene, or recombination activating 1, is fundamental for the proper functioning of the adaptive immune system. It directs the production of a protein that works alongside the RAG2 protein to form the RAG complex. This complex is critical for creating the wide array of immune receptors necessary for B and T cells to identify and combat diverse pathogens.

What the gene does

The RAG1 protein is a central component of the RAG complex, which is primarily active within lymphocytes (B cells and T cells). Its main role is in V(D)J recombination, a process where gene segments (variable, diversity, and joining) are rearranged to produce highly diverse receptor proteins on the surface of immune cells. This diversity allows the immune system to recognise a vast range of foreign invaders, such as bacteria, viruses, and fungi. The RAG complex initiates this process by binding to specific DNA sequences called recombination signal sequences (RSS) adjacent to the V, D, or J segments. It then makes precise cuts in the DNA, allowing these segments to be recombined in various ways. This DNA rearrangement is crucial for enabling B and T cells to mount an effective immune response against infections throughout an individual's life.

Video: Genetics 101

Chromosome location

The RAG1 gene is located on chromosome 11, specifically at position 11p12. This genomic location refers to the short (p) arm of chromosome 11, in region 12. The gene spans a particular segment of DNA on this chromosome, containing the instructions for the RAG1 protein.

Protein structure

The RAG1 protein consists of 1043 amino acids and features several distinct functional regions. The N-terminal region, spanning amino acids 1-288, is involved in interaction with importin alpha-1. There is also a disordered region from amino acids 40-80. Further along the protein, a RING-type zinc finger motif is found between amino acids 293-332, and another RAG1-type zinc finger is located from amino acids 354-383. A notable NBD (DNA binding) domain is present within amino acids 392-459, which is crucial for the protein's function in DNA recombination.

Domain map · 1,043 amino acids
Interaction with importin alpha-1 (1-288)RING-type (293-332)RAG1-type (354-383)NBD (392-459)Interaction with impor1-288RING293-332NBD392-4591~5221,043
Region - functional region
Zinc finger - zinc-binding structural motif
Region - functional region
🧬 Explore 3D structure on AlphaFold
UniProt:P15918Length:1,043 aaStructure:AlphaFold

Key variants

Variants within the RAG1 gene can lead to changes in the structure or function of the RAG1 protein. These genetic alterations can impact the protein's ability to facilitate V(D)J recombination, which is essential for immune system development. Such variants are typically inherited in an autosomal recessive pattern, meaning both copies of the gene must carry a pathogenic variant for a condition to manifest.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for RAG1.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.1180C>T
single nucleotide variant
p.Arg394Trp Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.1211G>A
single nucleotide variant
p.Arg404Gln Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.2487_2488delinsTT
Indel
p.Arg829_Lys830delinsSerTer Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.256_257del
Deletion
p.Lys86fs Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.2689C>T
single nucleotide variant
p.Arg897Ter Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.2877G>A
single nucleotide variant
p.Trp959Ter Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.2930del
Deletion
p.Met977fs Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.424C>T
single nucleotide variant
p.Arg142Ter Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.612G>A
single nucleotide variant
p.Trp204Ter Pathogenic ★★★☆ Recombinase activating gene 1 deficiency
c.999T>A
single nucleotide variant
p.Tyr333Ter Pathogenic ★★★☆ Recombinase activating gene 1 deficiency

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Variants in the RAG1 gene are associated with various primary immunodeficiency disorders. One well-characterised condition is Omenn syndrome, a severe form of combined immunodeficiency (SCID). SCID conditions are characterised by a profound lack of immune protection, making individuals highly susceptible to severe, recurrent infections. Other RAG1 variants can lead to distinct forms of SCID with varying degrees of B and T cell deficiency.

No condition pages are linked to this gene yet. This does not mean it has no associated conditions.

Inheritance pattern

Conditions caused by pathogenic RAG1 variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous RAG1 carrier status across ancestry groups?

UK clinical status

The RAG1 gene is included in several expert-curated panels within the NHS Genomic Medicine Service's PanelApp. It is listed as 'green' (meaning there is sufficient evidence for gene-disease association) for panels such as COVID-19 research, Gastrointestinal epithelial barrier disorders, Infantile enterocolitis & monogenic inflammatory bowel disease, Primary immunodeficiency or monogenic inflammatory bowel disease (R15), Rare genetic inflammatory skin disorders (R332), and Respiratory ciliopathies including non-CF bronchiectasis (R189).

Frequently asked questions

What is the RAG1 gene responsible for?

The RAG1 gene provides instructions for making a protein that is part of the RAG complex. This complex is essential for V(D)J recombination, a process that creates diverse immune cell receptors to help the body fight infections.

What happens if there are variants in the RAG1 gene?

Variants in the RAG1 gene can disrupt its normal function, leading to impaired immune system development. This can result in primary immunodeficiency disorders, such as Omenn syndrome, where the body has a reduced ability to fight off infections.

How is a condition related to RAG1 typically inherited?

Conditions associated with RAG1 variants are generally inherited in an autosomal recessive manner. This means an individual must inherit two copies of the altered gene, one from each parent, to develop the condition.

References

  1. Carmona LM, Schatz DG. New insights into the evolutionary origins of the recombination-activating gene proteins and V(D)J recombination. The FEBS journal. 2017. PMID: 27973733
  2. Bai X, Liu J, Zhang Z. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome. Immunologic research. 2016. PMID: 26476733
  3. Notarangelo LD, Kim MS, Walter JE. Human RAG mutations: biochemistry and clinical implications. Nature reviews. Immunology. 2016. PMID: 26996199
  4. Ru H, Chambers MG, Fu TM. Molecular Mechanism of V(D)J Recombination from Synaptic RAG1-RAG2 Complex Structures. Cell. 2015. PMID: 26548953
  5. Cassani B, Poliani PL, Moratto D. Defect of regulatory T cells in patients with Omenn syndrome. The Journal of allergy and clinical immunology. 2010. PMID: 20109747
  6. Somech R, Simon AJ, Lev A. Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells. The Journal of allergy and clinical immunology. 2009. PMID: 19767069
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .